CD4 and non-small cell lung carcinoma: Indeed, not only is PD-1 expression on CD4+ T cells significantly elevated in NSCLC patients compared with healthy subjects, but there is also a strong association between high expression of PD-1 on CD4+ T cells and poor survival outcomes [75,76].